FFA
TNGX icon

Farther Finance Advisors’s Tango Therapeutics TNGX Stock Holding History

Farther Finance Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
377
+5
+1% +$124 ﹤0.01% 4317
2026
Q1 		$7.89K Buy
372
+17
+5% +$237 ﹤0.01% 4258
2025
Q4 		$3.15K Buy
355
+330
+1,320% +$2.84K ﹤0.01% 4516
2025
Q3 		$210 Buy
+25
New +$169 ﹤0.01% 4710
2025
Q2 		– Sell
-1,572
Closed -$2.01K – 4655
2025
Q1 		$2.01K Buy
+1,572
New +$3.86K ﹤0.01% 3392
2024
Q4 		– Sell
-5
Closed -$39 – 4144
2024
Q3 		$39 Hold
5
– – ﹤0.01% 3884
2024
Q2 		$45 Hold
5
– – ﹤0.01% 3704
2024
Q1 		$38 Hold
5
– – ﹤0.01% 3487
2023
Q4 		$50 Buy
+5
New +$43 ﹤0.01% 3381

Other funds holding TNGX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Farther Finance Advisors's TNGX Position: Q2 2026 in Review

Farther Finance Advisors increased its Tango Therapeutics (TNGX) stake by 1.3% in Q2 2026, buying an estimated $124 and bringing the position to 377 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4317.

Farther Finance Advisors first reported a position in TNGX in Q4 2023 and has held it in 9 quarters since. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Farther Finance Advisors held 377 shares of Tango Therapeutics worth $11.8K as of Q2 2026.
  • Farther Finance Advisors bought 5 Tango Therapeutics shares in Q2 2026, an estimated $124.
  • Tango Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4317 holding.
  • Farther Finance Advisors first reported a position in Tango Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.